ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
jemperli
glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.
eprex 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjenih injekcijskih
raztopina za injiciranje - eritropoetin
eprex 30.000i.e./0,75 ml, raztopina za injiciranje v napolnjenih injekcijskih brizgah
raztopina za injiciranje - eritropoetin
eprex 40.000 i.e./1 ml raztopina za injiciranje v napolnjenih injekcijskih
raztopina za injiciranje - eritropoetin
eprex 40.000 i.e./1,0 ml raztopina za injiciranje v napolnjenih injekcijskih
raztopina za injiciranje - eritropoetin